The activated tyrosine kinase, Bcr-abl, is implicated in a number of hematopoietic malignancies. The exact biological mechanism by which the kinases transforms cells is still not well delineated. Previous data has suggested that the inhibition of apoptosis and the deregulation of cell cycle progression as the result of P210Bcr-abl expression might contribute to leukemogenesis. In vitro systems in which Bcr-Abl is over-expressed have concluded that similar growth regulatory pathways are aected as a result of the expression of both P210 and P190Bcr-abl. Here, we utilized an in vitro P190Bcr-abl leukemia mouse model to dissect the early events that contribute to transformation by this isoform of Bcr-Abl. In this mouse model P190Bcr-abl is expressed as a low but physiologically relevant level in that all mice develop pre-B leukemia lymphomas. We show that cell cycle and apoptotic responses to DNA damage are intact in bone marrow and spleen cells of such animals. We also demonstrate a normal induction of p21 WAF-1/CIP1 in both hematopoietic and non-hematopoietic tissue as a result of genotoxic stress. We suggest that P190Bcr-abl induced transformation is dierent than that of P210Bcr-abl.
Introduction
Bcr-abl or the Philadelphia chromosome (Ph) is a constitutively activated oncoprotein associated with hematologic diseases. Bcr-abl arises from a reciprocal translocation which juxtaposes sequences coding for the c-Abl tyrosine kinase on chromosome 9 downstream of one of two break-point sites in the BCR gene on chromosome 22 (Rowley, 1973; Konopka et al., 1984) . The larger of the two products, P210Bcr-abl, is a hall mark of chronic myelogenous leukemia (CML) while the other product, P190Bcr-abl, is associated with a more aggressive form of leukemia, mainly acute lymphoblastic leukemia (ALL) (Heisterkamp and Groen, 1991; Sawyers et al., 1991) .
In vitro cell culture experiments have suggested that both forms of Bcr-abl in¯uence identical signal transduction pathways that regulate cellular growth and proliferation. P210 and P190Bcr-abl are found associated with the adaptor protein GRB-2 in Phpositive cell lines, as well as in rat ®broblasts expressing one of the two oncoproteins (Pendergast et al., 1993) . This is one of several ways by which Bcr-abl activate the Ras pathway essential for transformation. Both Bcr-abl forms are present in signaling clusters with the adaptor proteins c-Cbl, c-Crk, and CrKL (Sattler et al., 1996) . These clusters were found to mediate the activation of the phosphatidylinositol-3' (PI3) kinase pathway (Sattler et al., 1996) . This is of importance to Bcr-abl transformation as PI3 kinase activation contributes to the inhibition of apoptosis (Yao and Cooper, 1995) . Furthermore, and in human acute myelogenous leukemia HL-60 cells stably transfected with P190Bcr-abl as well as in chronic myelogenous leukemia blast crisis K562 cells which express P210Bcr-abl, induction of apoptosis by treatment with anti-leukemic agents do not result in the cytosolic accumulation of cytochrome (Cyt) c, activation of caspase-3, or the other mitochondrial-induced perturbations associated with apoptosis (AmaranteMendas et al., 1998) . Both forms of Bcr-abl interact with signaling pathways, regulatory factors, and cellular structures involved in regulating cell adhesion (McWhirter and Wang, 1993; Salgia et al., 1995; Gotoh et al., 1995) . This leads to the constitutive activation of the focal adhesion kinase (FAK) (Gotoh et al., 1995) , redistribution of ®lamentous (F) actin (McWhirter and Wang, 1993) , and an increase in the level of spontaneous motility (Salgia et al., 1995) . Perturbation of cell cycle regulation is considered an early event in P210 and P190Bcr-abl oncogenesis (Cortez et al., 1997) . Inducible expression of both oncoproteins results in the activation of the cell cycle machinary, enhanced DNA synthesis, and the augmentation of mitogenic signals (Cortez et al., 1997) .
It is believed that the expression of P210Bcr-abl in the chronic phase of CML results in the loss of sensitivity to apoptosis (Bedi et al., 1994 (Bedi et al., , 1995 , reduction of cell adhesion (Salgia et al., 1995) , and failure to exit the cell cycle (Cortez et al., 1997) . This is thought to result in the expansion of the myeloid progenitor cell mass which facilitates the accumulation of additional genetic insults marking the onset of the terminal blast crisis.
P190Bcr-abl is associated with ALL which is considered as a distinct disease from acute phase CML (Berger, 1993) . We, therefore, decided to investigate the biological relevance of common regulatory pathways thought to mediate transformation by P210 and P190Bcr-abl. Speci®cally, we sought to determine whether lack of sensitivity to apoptosis and deregulated cell cycle control are early events in P190Bcr-abl oncogenesis. We utilized a P190Bcr-abl transgenic mouse model that succumbs to pre-B cell acute lymphoblastic leukemia after 100 days post natal on average (Heisterkamp et al., 1990) . In this leukemia mouse model, P190Bcr-abl is expressed from a truncated metallothieonin promoter to ensure a low level of expression of the kinase (Heisterkamp et al., 1990) . The utilization of the bcr promoter has proven to be embryonically lethal in mice. Before the onset of disease the transgene is expressed at low levels in most tissues tested (Heisterkamp et al., 1990; Voncken et al., 1992a) . During this pre-leukemic (PL) period the consequence of Bcr-abl expression on biological processes controlling genomic stability can be addressed. We suggest that these conditions are closer to what is encountered in leukemia patients than overexpressing Bcr-abl in tissue culture systems consisting of already immortalized cells. The P190Bcr-abl mouse model is also biologically relevant as most Ph + ALL pediatric patients carry the P190 variant of Bcr-abl and have a pre-B immunotype (Bloom®eld et al., 1989) .
We tested, in vivo, the integrity of the cell cycle check-points in bone marrow and spleen cells from irradiated P190Bcr-abl pre-leukemic transgenic mice. Both cell types did not exhibit an altered cell cycle arrest pattern compared to cells from normal mice. Concomitantly, we show that the G 1 cyclic-dependent kinase inhibitor WAF-1 (p21
) is normally induced in kidney, spleen, and lung of irradiated P190Bcr-abl mice. We also demonstrate, quantitatively and morphologically, that bone marrow and spleen cells from irradiated pre-leukemic P190Bcr-abl mice exhibit the same degree of apoptosis as cells from irradiated normal mice. This unaltered level of apoptosis was also observed in spleen and bone marrow cells from leukemic mice as well as tumor tissue dissected from such mice. Our data suggests that the expression of P190Bcr-abl at a level sucient to induce acute leukemia in an animal model does not interfere with the two biological processes regarded as the primary safeguards against the accumulation of mutations and preserving genomic stability.
Results

Cell cycle regulation in bone marrow cells from G-CSF treated mice
The principal role of the cell cycle is to ensure the ®delity of DNA replication and chromosomal segregation. In the event of in-born error or exogenous genotoxic stress, cellular mechanisms have evolved that can impede the progression of the cell cycle and by that circumvent the ampli®cation of such error. The expression of both P190 and P210 Bcr-abl in 32D cells was shown to result in the inhibition of cell cycle exit, stimulation of G 1 -to-S phase transition, and activation of mitogenic signaling pathways (Cortez et al., 1997) . We decided to test whether the expression of the P190Bcr-abl constitutive tyrosine kinase in mouse tissue interferes with the ability of cells to regulate cell cycle progression following the induction of DNA damage by g-irradiation. Normal mice utilized in those and subsequent experiments have the same genetic background (F 1 C57BL 66CBA) as P190Bcr-abl mice. Normal, pre-leukemic P190Bcr-abl, and p53
7/7
knock-out mice were injected with granulocyte colony stimulating factor (G-CSF) for 3 days. This resulted in the increase of the percentage of proliferating cells in the bone marrow at dierent animals from 4 ± 5% in non-stimulated mice to 18 ± 25% in stimulated mice. This allowed the monitor of the decline of cells in the S phase of the cell cycle following the induction of DNA damage and the activation of the G 1 and G 2 check points. Dierential analysis of peripheral cell blood counts (CBC) performed on individual mice indicated an increase in monocytes and neutrophils after G-CSF treatment (data not shown). Cells in the S phase of the cell cycle were labeled in vivo by injecting mice with bromodeoxyuridine (BrdU) for 4 h prior to their sacri®ce. Utilizing an irradiation dose of 2 Gy. And studying cell cycle pro®les 24 h post-irradiation, we found a normal arrest in cell cycle progression in bone marrow cells from both P190Bcr-abl and normal irradiated mice (Figures 1 and 2a) . Cell cycle pro®les were determined by labeling bone marrow cells dissected from mice with¯uorescein anti-BrdU antibodies and propidium iodide (PI). Cells were then analysed by dual¯ow cytometry for anti-BrdU (y-axis) and PI (xaxis) (Figure 1 ). Under each dual¯ow cytometric analysis, the cell cycle distribution of the same sample is represented by PI staining alone. The arrest in cell cycle was re¯ected by a decrease in the amount of cells in the S phase of the cell cycle (Figure 1 ). Bone marrow cells from irradiated normal mice (n=4) demonstrated a 35% decrease in cells in the S phase of the cell cycle compared to bone marrow cells from unirradiated mice (n=4) (Figure 2a ). This dierence was statistically signi®cant (P=0.011). This was paralleled by nearly an identical decrease in bone marrow cells from irradiated pre-leukemic P190Bcr-abl (35.1%) (n=6) compared to non-irradiated mice (n=5) (P50.001). Bone marrow cells from irradiated p53 7/7 mice (n=4) showed only a 15.5% decrease in cells in the S phase of the cell cycle compared to nonirradiated mice (n=4) which was statistically insignificant (P=0.07). The arrest was mainly at the G 1 phase of the cell cycle as the decrease in cells in S phase was accompanied by an increase of cells accumulating at G 1 (Figure 2a) .
The G 2 /M cell cycle check-point also responded normally in bone marrow cells from P190Bcr-abl mice treated with G-CSF but irradiated at 6 Gy and analysed at an earlier time point (12 h) (Figure 2b ). Irradiation resulted in a decrease in the fraction of bone marrow cells in S phase from both P190Bcr-abl mice (n=4, P50.001) and normal controls (n=4, P=0.002) (Figure 2b . This was accompanied by an increase in the fraction of cells at G 2 /M in bone marrow cells from P190Bcr-abl mice (P50.001) as well as normal mice (P=0.029) (Figure 2b ).
Cell cycle regulation in bone marrow cells from IL-2 treated mice G-CSF mainly stimulates the proliferation of granulocytes of the myeloid lineage. Whereas the expression of P190Bcr-abl messages was detected in most tissues (Voncken et al., 1992a) , P190Bcr-abl mice usually succumb to lymphomas (Heisterkamp et al., 1990; Voncken et al., 1992a) . This led us to investigate whether following the induction of DNA damage the expression of P190Bcr-abl in lymphoid cell progenitors in the bone marrow results in a cell cycle arrest pattern dierent than that observed in myeloid cells from the bone marrow. Mice were injected with IL2 for 3 days to expand both the T-and B-lymphocytes cell pools. CBC dierential analysis indicated an increase in lymphocytes in peripheral blood samples (data not shown). IL2-treated normal (n=4), pre-leukemic P190Bcr-abl (n=4), and p53 7/7 (n=3) mice were irradiated at a dose of 6 Gy. Twenty-four hours post-irradiation, the cell cycle pro®les of bone marrow cells from both irradiated and non-irradiated mice (P190Bcr-abl and normal mice n=4, p53 7/7 n=4) were Figure 1 Flow cytometric analysis of cell cycle response in bone marrow cells from mice treated with G-CSF. Pre-leukemic P190Bcr-abl (P190Bcr-abl), normal, and p53 7/7 knock-out mice were stimulated with G-CSF for 3 days after which they were irradiated. Twenty hours later mice were injected with BrdU to label replicating cells. Mice were sacri®ced 4 h later and bone marrow cells were removed from femurs and labeled with FITC-conjugated aBrdU antibody (y-axis) and propidium iodide (x-axis). Cells were then analysed using¯ow cytometry Early events in P190Bcr/abl leukemogenesis HF Salloukh et al determined ( Figure 3a) . In normal mice, a 48% decrease in cells in the S phase of the cell cycle was observed following irradiation, compared to nonirradiated mice (P50.001). Also, a 61% decrease in bone marrow cells in the S phase of cell cycle was observed in similarly treated P190Bcr-abl mice (P50.001), while only an 18.8% decrease in the same cells from p53
mice was detected, which was statistically insigni®cant (P=0.075) (Figure 3a ). Cells from normal and P190Bcr-abl mice demonstrated a signi®cant (P50.001) increase in cells arrested at G 1 after irradiation. A signi®cant dierence, however, in the kinetics of G 2 /M arrest was observed. In irradiated P190Bcr-abl mice a 30% increase (P=0.012) in the cell Figure 2 Normal activation of G 1 and G 2 cell cycle arrest in bone marrow cells from pre-leukemic P190Bcr-abl mice treated with G-CSF. Normal (Nor), pre-leukemic P190Bcr-abl (P190), and p53 7/7 knock-out mice were treated with G-CSF for 3 days after which half of the mice were irradiated at a dose of 2 Gy (a) or 6 Gy (b). Twenty (a) or 8 (b) h layer, mice were injected with BrdU for 4 h and subsequently sacri®ced and the cell cycle pro®les of bone marrow cells was determined by¯ow cytometry. Each data point in (a) represents four mice (normal, p53
), ®ve mice (iradiated P190), or six mice (non-irradiated P190). In (b) each data point represents four mice population in the G 2 /M phase of the cell cycle was observed compared to only 12% in irradiated normal mice (P=0.222), while in p53
mice a twofold increase in arrested at G 2 /M was noted ( Figure 3a) . However, these results demonstrate that normal cell cycle responses to irradiation exist in lymphocytes from the bone marrow of P190Bcr-abl mice.
Cell cycle regulation in spleen cells from IL-2 and aCD3 treated mice
We were interested in ®nding out whether lymphocytes in other hematopoietic tissues from P190Bcr-abl mice demonstrate a normal cell cycle arrest following irradiation. Lymphocytes in spleens of normal, Figure 3 Normal cell cycle response to irradiation in lymphocytes from pre-leukemic P190Bcr-abl mice treated with IL-2 and IL-2 + aCD3. Normal, pre-leukemic P190Bcr-abl (P190), and p53 7/7 were treated with IL-2 (a) or IL-2 and aCD3 (b) after which half of the mice were irradiated (6 Gy). Twenty hours later, mice were injected with BrdU for 4 h at the end of which they were sacri®ced and the cell cycle pro®les of bone marrow cells (a) and spleen cells (b) were determined by¯ow cytometry P190Bcr-abl, and p53 7/7 mice were stimulated by administering aCD3 antibody and IL-2 for 3 days. Following irradiation (6 Gy), we noticed a decrease in the S phase population of spleen cells from irradiated normal (66%) (P=0.009) and pre-leukemic P190Bcr-abl (61%) (P=0.01) mice (n=3) (Figure 3b ) compared to matched non-irradiated mice (n=3). This was accompanied by a cell cycle arrest at the G 0 /G 1 phase in both normal (P=0.003) and P190Bcr-abl (P=0.006) mice. In p53 7/7 (n=3) mice, no statistically signi®cant change in S phase was observed and although a slight increase in cells arresting at the G 2 /M phase of the cell cycle was detected it was of no statistical signi®cance (P=0.591) (Figure 3b) . Bedi et al. have previously shown that resistance to apoptosis in P210Bcr-abl is accompanied by the accumulation of cells at G 2 /M which might allow the repair of cells which otherwise are prone to undergo apoptosis (Bedi et al., 1995) . However, the dierence in the kinetics of G 2 /M arrest in spleen cells from P190Bcr-abl mice was not accompanied by a decrease in apoptosis (data not shown).
P21
WAF-1/CIP1 induction Cells exposed to genotoxic stress block cell cycle progression at the G 1 /S stage of the cell cycle, thus avoiding the replication of damaged DNA, and allowing time for repair. The failure of such a mechanism results in the ampli®cation of genetic damage and gives rises to genomically unstable clones. P21 WAF-1/CIP1 plays an important role in regulating the G 1 /S checkpoint. Following DNA damage WAF-1 is transcriptionally activated by p53 and directly inactivates multiple cyclin-cyclin-dependent kinase complexes necessary for progression through G 1 /S (Hall and Peters, 1996; Cox, 1997) . We investigated whether the expression of P190Bcr-abl in pre-leukemic mice has any eect on the induction of WAF-1 following exposure to g-irradiation. We compared the eect in hematopoietic and non-hematopoietic tissue all of which have been previously shown to express the activated kinase (Heisterkamp et al., 1990; Voncken et al., 1992a) . Three hours following whole body irradiation (10 Gy), WAF-1 induction was observed by Northern blot analysis of total RNA from irradiated spleen, lung ( Figure 4a ) and kidney ( Figure  4b ) in both normal and pre-leukemic P190Bcr-abl, but not in p53 7/7 mice. An increase in WAF-1 level was also detected in spleen, lung ( Figure 4a ) and kidney ( Figure 4b ) dissected from leukemic P190Bcr-abl mice (LP190Bcr-abl). We speculated that perhaps the induction of WAF-1 is lost as a result of cells undergoing transformation. Tumor tissues from leukemic mice were, therefore, dissected following irradiation and WAF-1 levels were investigated at the same Figure 4 Normal induction of p21 WAF-1/CIP1 in pre-leukemic P190Bcr-abl mice. Total RNA from spleen, kidney, and lung tissue was extracted from both non-irradiated (0 Gy) and irradiated (10 Gy) normal (Nor), pre-leukemic P190Bcr-abl (P190), p53
, and leukemic P190Bcr-abl mice (LP190). An increase in p21 WAF-1/CIP1 message following irradiation was detected in spleen and lung from normal, pre-leukemic P190Bcr-abl, and leukemic P190Bcr-abl mice (a). Normal WAF-1 induction was also detected in kidneys from normal, pre-leukemic P190Bcr-abl, and leukemic P190Bcr-abl as well as in lymphoma tissue dissected from leukemic P190Bcr-abl mice (b). Two mice of each type were examined time point described above. Tumor tissue (Tumor-1 and 2, Figure 4b ) from two dierent mice showed a normal increase in WAF-1 levels following irradiation. These experiments con®rm that the induction of p21 WAF1/CIP1 is intact in spleen, kidney, and lung tissue from pre-leukemic and leukemic P190Bcr-abl mice as well as in tumor tissue dissected from leukemic mice.
Apoptosis in pre-leukemic P190Bcr-abl mice
Inhibition of apoptosis by P210Bcr-abl is thought to play a fundamental role in leukemogenesis by selectively increasing the survival of Bcr-abl + clones (Laneuville et al., 1994; Bedi et al., 1994 Bedi et al., , 1995 . In the pre-B cell line BaF3, the expression of P210Bcr-abl Figure 5 Increase in the level of apoptosis in bone marrow and spleen cells from pre-leukemic P190Bcr-abl and control mice following irradiation. Mice were irradiated at 6 Gy and sacri®ced 14 h later. The level of apoptosis was determined quantitatively bȳ ow cytometry. Cells were determined to be apoptotic if they had a sub-diploid DNA content as determined by propidium iodide labeling (x-axis). An increase in apoptosis following irradiation was detected in bone marrow and spleen cells from pre-leukemic P190Bcr-abl (P190) and normal (Nor) mice but not p53 7/7 knock-out mice. Each data point represents the average of four dierent mice confers resistance to apoptosis (Bedi et al., 1995) . In the same system, an intact G 1 /S cell cycle response and induction of P21 WAF1/CIP was observed following exposure to ionizing radiation. We were interested in investigating whether the expression of P190Bcr-abl during the pre-leukemic stage in the leukemia mouse model interferes with the regulation of apoptosis. Apoptosis was measured in vivo in bone marrow and spleen cells from irradiated (6 Gy) (n=4) and control non-irradiated mice (n=4). Quanti®cation of apoptosis was achieved by staining with propidium iodide (xaxis) and scoring cells with sub-diploid DNA content by¯ow cytometric analysis.
In bone marrow cells from irradiated normal mice a three fold increase in cells undergoing apoptosis compared to non-irradiated mice was observed (P50.001) (Figures 5and 7) . A comparable 3.8-fold increase in cells undergoing apoptosis was observed in spleen cells from the same set of mice (P50.001) (Figures 5 and 7) . In irradiated pre-leukemic P190Bcr-abl mice, a 2.8 and a 2.3-fold increase in the quantity of apoptotic cells was observed in spleen (P=0.001) and bone marrow cells (P50.001) (Figures 5 and 7) respectively, compared to cells from non-irradiated preleukemic mice. The p53 gene product is indispensable for the induction of apoptosis following exposure to radiation-induced DNA damage (Agarwal et al., 1998) . p53 7/7 knock-out mice were used as a negative control for apoptosis. Spleen cells from irradiated p53 7/7 mice showed no signi®cant change in the level of apoptosis Figure 6 Increase in the level of apoptosis in spleen, bone marrow, and lymphoma cells from irradiated leukemic P190Bcr-abl mice. Mice were irradiated at 6 Gy (right panel) and sacri®ced after 14 h. The level of apoptosis was determined by¯ow cytometry as previously described. Each data point represents one mouse Oncogene Early events in P190Bcr/abl leukemogenesis HF Salloukh et al compared to unirradiated p53 7/7 controls (P=0.855), while in bone marrow cells only a 1.4-fold increase was observed as a result of irradiation (Figures 5 and 7) .
The levels of apoptosis following irradiation was also determined in bone marrow and spleen cells from mice that have already developed leukemia ( Figure 6 ). This was done to determine whether leukemic transformation might lead to the abrogation of apoptosis suggesting that such an abrogation is a late step in disease progression. Also in hematopoietic cell lines inhibition of apoptosis was only detected in clones that express high levels of Bcr-abl (Cambier et al., 1998) . High levels of P190Bcr-abl are expressed in lymphomas from leukemic mice permiting detection by Western blot analysis (Figure 8 ). We also show that following the onset of acute leukemia an increase in expression also occurs in tissue such as spleen (Figure 8 ) which express P190Bcr-abl at levels detected only by RT ± PCR during the pre-leukemic stage. However, a 2.4-fold increase was observed in bone marrow cells from irradiated leukemic (L) P190Bcr-abl mice (n=4), compared to non-irradiated leukemic mice (n=3) (P=0.005) (Figures 6 and 7) . Also a 2.4-fold increase in cells undergoing apoptosis was observed in spleens from irradiated L P190Bcr-abl (n=5) compared to non-irradiated mice (n=3) (P50.001) (Figures 6 and  7) . We also observed a threefold increase in cells undergoing apoptosis when tumor tissues from an irradiated leukemic P190Bcr-abl mouse was compared to the same tissue dissected from a leukemic unirradiated P190Bcr-abl mouse ( Figure 6 ). These results suggest that normal apoptotic responses are present even in tumor tissue which abundantly express P190Bcr-abl (Figure 8 ).
Typical apoptotic morphology resulting from DNA fragmentation was observed in cells from irradiated mice by DNA staining with acrydine orange (data not shown).
Discussion
In this study, we have decided to utilize an in vitro acute leukemia mouse model transgenic for P190Bcr-abl to determine the early consequences of P190Bcr-abl expression on mechanisms safeguarding genomic stability. We have previously shown that mice transgenic for this Bcr-abl DNA construct succumb to pre-B lymphoid leukemia similar in its rapidity and type to that of human acute leukemia (Heisterkamp et al., 1990) . We have decided to perform these experiments in vivo in order to assess the primary eect of P190Bcr-abl expression in the context of intact cellular functions. Mice were con®rmed to be disease-free by the examination of blood and bone marrow smears for the presence of leukemic cells (data not shown). Mice were irradiated and cell cycle pro®les as well as apoptotic levels were measured from freshly dissected Figure 7 Summary of apoptosis experiments in bone marrow and spleen cells. Irradiation-induced apoptosis was measured in bone marrow (a) and spleen (b) cells from normal (Nor), preleukemic P190BCR-ABL (P190), leukemic P190BCR-ABL (LP190), and p53 7/7 knock-out mice. Apoptotic levels in irradiated (6 Gy) mice were compared to those in unirradiated counterparts. Each data point represents an average of four dierent mice in normal, P190, and irradiated LP190 mice or three in p53
, and non-irradiated LP190 mice Figure 8 P190Bcr-abl expression in leukemic mice. A high molecular weight protein marker (M) is indicated to the left. Expression of P190Bcr-abl is detected in total protein from the spleen of a leukemic P190Bcr-abl mouse (L Spleen) as well as from lymphoma dissected from a leukemic mouse (Tumor) bone marrow and spleen cells. We used p53 7/7 nullizygous mice as both technical and physiological controls. As expected, there was neither a G 1 /S cell cycle arrest nor an increase in apoptotic levels in bone marrow and spleen cells derived from p53 7/7 mice. Here we show that in both bone marrow and spleen cells from pre-leukemic P190Bcr-abl transgenic mice, genotoxic stimuli as a result of irradiation does not result in an aberrant response. Cell cycle arrest and induction of apoptosis following irradiation was comparable to that found in normal mice. This was accompanied by an elevation in the level of p21 WAF1/CIP-1 con®rming a normal cell cycle response following genotoxic stress.
Transgenic mice models for human diseases are a major tool for the understanding of the molecular basis of such diseases. These mouse models are also important as they can be used to test the feasibility of dierent therapeutic interventions. Several leukemia mouse models that replicate the human disease with high ®delity have been described (Kelliher et al., 1990; Daley et al., 1990; Heisterkamp et al., 1990; Voncken et al., 1995; Honda et al., 1998) . Early mouse models for leukemia relied on retroviral expression of P210Bcr-abl in mouse hematopoietic stem cells which were subsequently used to reconstitute irradiated mice marrow (Daley et al., 1990) . Myeloproliferative syndromes resembling human CML with similar pathologic characteristics such as granulocytosis and splenomegaly developed. An alternative method to establish Bcr-abl-mediated leukemia mouse models is through the utilization of transgenic technology. This circumvents complications that may arise from experimental conditions such as retroviral infection and bone marrow culture conditions that might bias the representation of a hematopoietic subset (Vonken et al., 1995) .
In the P190Bcr-abl mouse model that we utilize in this study, the expression of Bcr-abl is driven from a truncated metallothieonin (MT) promoter. This ensures the expression of P190Bcr-abl in every cell type including hematopoietic cells (Hiesterkamp et al., 1990) . The expression of Bcr-abl driven from the bcr promoter is embryonically lethal in mice. Nevertheless, MT-driven expression is ideal for our study as we attempt to investigate the early biological changes that occur after the expression of P190Bcr-abl. This model is dierent from cell line systems in that Bcr-abl is expressed at a low level in the context of otherwise normal cells with intact physiological functions. The low level of expression is relevant given that all mice subsequently develop leukemia. We have previously shown using RT ± PCR the expression of P190Bcr-abl in bone marrow and spleen cells at the age group utilized in experiments described here (4 weeks of age) (Voncken et al., 1992a) . At this PL stage all mice were karyotypically normal, have a normal peripheral white blood cells (WBC) counts, and show no sign of leukemic cells in the bone marrow or peripheral blood (data not shown). We and others were only able to show protein expression by Western blot analysis in tumor tissue of mice with acute leukemia Honda et al., 1998) (Figure 8 ). The level of P190Bcr-abl expression in bone marrow and spleen cells from PL P190Bcr-abl mice is many-fold less than in cultured cells transiently or stably expressing Bclabl (Voncken et al., 1992a ). However we have previously shown that Bcr-abl mRNA was detected as early as one stage embryo and was found in all tissues examined in a later stage (Voncken et al., 1992a) . Prolonged expression of Bcr-abl in the brain, liver, kidney, spleen, and muscle was also detected in the progeny of the mouse line 623 used here (Voncken et al., 1992a) . Expression in tissue other than the bone marrow did not appear to be due to Bcr-abl expressing bone marrow cells escaping from circulation, as peripheral blood samples of the same mice were negative for Bcr-abl expression (Voncken et al., 1992a) .
After establishing that the expression of P190Bcr-abl in what we consider to be the pre-leukemic stage does not lead to the inhibition of cell cycle regulation or apoptosis following genotoxic stress, we asked whether this is true for mice with acute leukemia. We rationalized that perhaps the loss of those two regulatory processes is due to disease progression rather than a cause for disease initiation. Also in vitro studies have shown a correlation between the levels of Bcr-abl expression in hematopoietic cell lines and inhibition of apoptosis (Cambier et al., 1998) . Only clones expressing high levels of Bcr-abl were resistant to apoptosis. However, we also observed an increase in apoptosis in spleen and bone marrow cells from leukemic mice following irradiation (Figure 7) . The level of P190Bcr-abl expression in leukemic cells is higher than that observed in the same cells from preleukemic mice. Whereas expression is only detected by RT ± PCR in spleens from pre-leukemic mice, we observe an increase in expression permitting detection by Western blot in the same cells but from leukemic mice (Figure 8 ). In addition, we observed normal induction of apoptosis ( Figure 6 ) and WAF-1 ( Figure  4B , Tumors 1 and 2) in tumor tissue from leukemic mice where the expression of P190Bcr-abl is 100-fold more than that in spleen cells from pre-leukemic mice (Voncken et al., 1992a) and much higher than spleen cells from leukemic mice (Figure 8 ). It is intriguing that in ALL patients as well as CML patients in the blast crisis, apoptosis can be induced to high levels (80% of leukemic cells in peripheral blood and bone marrow) using a variety of chemotherapeutic drugs (Li et al., 1994) . This presents further evidence that inhibition of apoptosis is not an early event in P190Bcr-abl-induced transformation. In addition to dierences in P190Bcr-abl expression levels discussed above, leukemic P190Bcr-abl mice are also hematologically dierent from PL P190Bcr-abl mice. They demonstrate a high WBC count (50 ± 100610 9 /litre) of which most are lymphoblasts (data not shown). Bone marrow smears show little evidence of hematopoietic dierentiation and consists mainly of blast cells (data not shown). Also, we have shown earlier the extensive involvement of both splenic white and red pulp with neoplastic lymphoblasts (475%) (Heisterkamp et al., 1990) .
The major focus of the work presented here is to determine the early consequences of P190Bcr-abl expression. We have shown that the expression level of P190Bcr-abl in PL mice is more that 100-fold lower than that in Ph + cell lines such as K562 . We presume that the level of expression of P190bcr-abl in PL mice is more comparable to patients with Ph + leukemia than cell lines that over-express P190Bcr-abl. Part of understanding the early events in P190bcr-abl transformation is the lack of`pre-leukemic' phase in patients with ALL. We suggest that experiments done in PL P190Bcr-abl mice aimed at determining early events in P190Bcr-abl leukemogenesis can shed light on mechanisms targeted early in the progression of Ph + ALL. In vitro cell culture systems used to investigate such mechanisms may have some limitations. First, most of these systems consist of already immortalized cells or primary cells from patients in the acute phase of the disease. Second, many of these systems overexpress the P190Bcr-abl oncoprotein. Furthermore, the transgenic P190Bcr-abl mouse model used here results in pre-B cell leukemia-lymphoma similar to most pediatric patients with Ph + ALL (Bloom®eld et al., 1989; Hiesterkamp et al., 1990) . In addition, we have shown that a key adaptor protein, Crkl, whose phosphorylation by P190Bcr-abl is likely to contribute to development of acute leukemia in humans (ten Hoeve et al., 1994) is also phosphorylated in leukemic tissue from P190Bcr-abl mice but not in non-leukemic cells (de Jong et al., 1995) . We have also shown that Hef-1, a member of the b integrin signaling pathway, is tyrosine phosphorylated in both P190Bcr-abl expressing leukemic cells and pH + blood samples of ALL patients, but not in the P210Bcr-abl + CML cell line K562 (de Jong et al., 1997) . These observations in addition to demonstrating the similarity of the P190Bcr-abl leukemia mouse model to human ALL, also point to dierences between P190 and P210Bcr-abl leukemogenesis. Indeed, we have previously shown that P190 and P210Bcr-abl have distinct leukemogenic eect in mice with P210-associated leukemias showing a longer latency time .
We have previously shown that the expression of P190Bcr-abl in mice results in genomic instability characterized by non-random numerical changes accompanying the onset of leukemia in those mice (Voncken et al., 1992b) . Normal karyotypes were observed in the initial stages of P190Bcr-abl expression in those mice. This suggests that the P190Bcr-abl is solely responsible for the increase in mutational activity leading to the onset of leukemia. It is, therefore, possible that the expression of P190Bcr-abl might initially aect biological processes such as DNA repair and replication. Recently, an increase in spontaneous mutations at the Na-K-ATPase and the HPRT loci was reported in BaF3 cell lines transfected with both P210 and P190 Bcr-abl oncogenes (Canitrot et al., 1999) . This spontaneous mutator phenotype was accompanied by an increase in the expression and activity of DNA polymerase b. This polymerase lacks exonuclease activity and seems to be the least accurate of the ®ve mammalian DNA polymerases (Kunkel, 1985) . Work is underway to demonstrate that a similar mutator phenotype is responsible for the onset of leukemia in the PL stage of P190Bcr-abl mice. If an increase in mutation frequencies is observed in the PL stage, then we propose that the reversal of such a phenotype can serve as a basis to test potential therapeutic strategies for the treatment of pH + acute leukemias. Given that Ph + leukemias are progressive diseases, the reversal of the initial mutagenic event triggered by the kinase can delay the onset of later stages of the disease.
Materials and methods
Animals
P190Bcr-abl transgenic mice are described in detail elsewhere (Heisterkamp et al., 1990) . The transgene construct used to generate those mice codes for the human P190Bcr-abl fusion protein under the control of the mouse metallothionine-1 promoter (Heisterkamp et al., 1990) . Founder animals were the ospring of mating between C57BL6CBA F 1 , while transgenic progeny was the result of mating between transgenics and C57BL6CBA F 1 mice. A homozygote colony of P190Bcr-abl mice was established through breeding. p53 7/7 null mutant mice contain a Po1II-neo expression cassette interrupting exon 5 of the p53 gene resulting in the absence of p53 protein expression in all tissues of the animal (Donehower et al., 1992) . p53 homozygote null (p53
) as well as, heterozygote (p53 7/+ ) mutants were established under a breeding licence from Taconic Farms Inc (NY, USA). Normal mice used as control in experiments were from a similar genetic background as P190Bcr-abl (F 1 C57BL/CBA) (Jackson, USA) and p53
(C57BL/6) (Charles River, Canada). Where indicated, genotoxic stress by ionizing radiation was induced by subjecting mice to whole body irradiation at dierent doses (2, 6, 8, and 10 Gy) at a rate of 107 cGy/min from a 60 Co (Cobalt) source. P190Bcr-abl in the pre-leukemic phase were con®rmed to be disease free by studying the morphology of blood and bone marrow smears for the presence of immature blast cells.
Expansion of replicating cell pool in vivo
Mice were sub-cutaneously injected with human granulocyte colony-stimulating factor (G-CSF) (Amgen, Ontario, Canada) for 3 days at a dose of 5 ng/g mouse body weight. This resulted in a 4 ± 5-fold increase of granulocyte precursor cells in the S phase of the cell cycle in bone marrow. Similarly, mice were injected intra-peritoneally with 10 000 cetus units of human IL2 (Amgen, Ontario, Canada) for 3 days to expand the lymphoid precursor cell population in the bone marrow.
In addition, we were able to increase lymphocyte counts in the spleen by injecting mice intra-peritoneally with 0.1 mg/gm mouse body weight of anti-CD3 (anti-mouse T3 CD3e complex) antibody (CedarLane, Ontario, Canada) for 3 days and rat Interleukin 2 (IL-2) (CedarLane, Ontario, Canada) at a dose of 10 000 cetus unit/mouse. Cell blood counts (CBC) of blood samples from induced mice were performed to obtain a pro®le of the dierent blood lineages and to con®rm the increase of targeted populations in peripheral blood.
Southern blots
Tail DNA for mice genotyping was processed as described previously (Hiesterkamp et al., 1990) . Fifteen mg of DNA was digested (XhoI and HindIII for P190Bcr-abl mice, BamHI for p53 mice), ran on a 1% agarose gel, and transferred onto hybond N + nylon membranes (Amersham, Ontario, Canada). For P190Bcr-abl genotyping, membranes were hybridized with a 600 bp XhoI/Bg1II fragment of the bcr sequences in the transgene (Heisterkamp et al., 1990) . p53 7/7 mice were genotyped according to the suppliers protocol using a 600 bps. KpnI probe that can hybridize to exons 2 ± 6 of the p53 gene. After hybridization blots were washed at room temperatures (16SSC, 0.1% SDS) and at 658C before being exposed to all purpose hyper sensitivity ®lm (Amersham, Ontario, Canada).
Northern blot analysis
Total RNA was isolated from 100 mg mice tissue by homogenizing in 1 ml of Trizol TM (Gibco BRL, Ontario, Canada) according to the manufacturer's protocol. Twenty mg of total RNA was denatured and electrophoretically separated on 1.2% formaldehyde-agarose gels. The separated RNA was then transferred onto a hybond N + nylon membrane (Amersham, Ontario, Canada) and WAF-1 (p21 ) mRNA detected by probing the membrane with an EcoRI fragment of the mouse waf-1 cDNA in BlueScript SK (Macleod et al., 1995) (generous gift from Dr Bert Vogelstein). Post-hybridization washes were done at room temperature (16SSC, 0.1% SDS) and then at 628C (0.26SSC, 0.1% SDS).
Determination of cell cycle distribution by BrdU and propidium iodide labeling
Cells from mice labeled in vivo with bromodeoxyuridine (BrdU)(Sigma, Ontario, Canada) were analysed for cell cycle distribution by using¯uorescein conjugated anti-BrdU antibody (Becton Dickinson, Quebec, Canada) following a protocol supplied by the manufacturer. Replicating cells an irradiated (2, 4, 6 and 8 Gy) and control (0 Gy) mice treated with G-CSF, IL-2, or a combination of IL-2 and aCD3 antibodies were labeled in vivo by injecting mice intra-peritoneally with BrdU at a dose of 50 mg/g body weight. Mice were treated with BrdU either 20 or 8 h following irradiation. Unirradiated mice were treated with BrdU at similar time points. Mice were usually sacri®ced by cervical dislocation 4 h after injecting with BrdU. Bone marrow cells were¯ushed out of femurs with aMEM media (Gibco BRL, Ontario, Canada), while spleens were removed and crushed manually by passing through a sieve. Cells were washed twice with phosphate-buered saline (PBS) (Gibco BRL, Ontario, Canad), ®xed in ice-cold 70% ethanol, and then incubated for 30 min at 48C. Fixed cells were then denatured in 2 N HCl with 0.5% (v/v) Triton X-100 (BioRad, Ontario, Canada) for 1 h at room temperature, and subsequently neutralized in 0.1 M sodium borate. Approximately 10 6 cells of each sample were permeabilized by re-suspending in 50 ml of 0.5% (v/v) Tween-20 (BioRad, Ontario, Canada) and 1% (w/v) bovine serum albumin (BSA) (Sigma) in PBS. Twenty ml of¯uorescein anti-BrdU anti-body (Becton Dickinson) were added to each sample and incubated for 30 min in the dark at room temperature. Cells were then resuspended in 1 ml PBS containing 5 mg of propidium iodide (PI) (Sigma, Ontario, Canada). The cell cycle pro®le of each sample was determined by dual-color¯ow cytometric analysis for DNA content (PI) and cells in S phase of the cell cycle (FITC + ) using a FACScan (Becton Dickinson). Data from¯ow cytometry was analysed using Mod®t and Winlist software (Verity Software House, ME, USA) to determine the proportion of cells in dierent phases of the cell cycle.
Quantitative assay and morphological determination of apoptosis
The level of apoptosis in irradiated (6 and 8 Gy) and control unirradiated mice were determined by propidium iodide (PI) staining. Fourteen hours post-irradiation mice were sacri®ced, bone marrow cells were¯ushed out of femur, and spleen and tumor tissue surgically removed and homogenized manually by passing through a ®ne sieve. Cells were then washed and permeabilized as described in the previous section and then resuspended in 1 ml of PBS containing 5 mg of propidium iodide. Cells were then analysed using a FACScan (Becton Dickinson). Quanti®cation of apoptotic cells with sub-diploid DNA was achieved using Mod®t and Winlist computer software (Verity Software House, ME, USA).
Typical apoptotic morphology was shown by mounting spleen and bone marrow cells from irradiated mice stained with 5 mg/ml acridine orange (Sigma, Ontario, Canada) in PBS on microscopic slides and observing under a¯uorescent microscope.
Immunoblots
Spleen and tumor tissues from leukemic P190Bcr-abl mice were mechanically homogenized in cold lysis buer (50 mM HEPES pH 7.9, 600 mM KCl, 0.1% NP40, 10% glycerol, 4 mM NaVO 3 , 4 mM NaF, 2 mM EDTA, 2 mM EGTA, 5 mM DTT, 0.5 mM PMSF, and 1 mg/ml Pepstastin and Leupeptin). One hundred mg of protein per lane were separated on SDS ± PAGE gels and transferred to PVDF membranes. The human P190Bcr-abl and mouse c-Abl were detected with the mouse monoclonal antibody Ab-3 (Oncogene Science, Calbiochem, Ontario, Canada).
Statistical analysis
In cell cycle and apoptosis experiments, changes in the fraction of cells in dierent cell cycle stages or undergoing apoptosis as a result of irradiation were compared to nonirradiated samples by determining P-values using the Student t-test (Sigmastat).
